339 related articles for article (PubMed ID: 35582651)
1. GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer.
Rodríguez De Dios N; Navarro-Martin A; Cigarral C; Chicas-Sett R; García R; Garcia V; Gonzalez JA; Gonzalo S; Murcia-Mejía M; Robaina R; Sotoca A; Vallejo C; Valtueña G; Couñago F
World J Clin Oncol; 2022 Apr; 13(4):237-266. PubMed ID: 35582651
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer.
Wujanto C; Vellayappan B; Siva S; Louie AV; Guckenberger M; Slotman BJ; Onishi H; Nagata Y; Liu M; Lo SS
Front Oncol; 2019; 9():1219. PubMed ID: 31799188
[TBL] [Abstract][Full Text] [Related]
3. Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution.
Doupnik NP; Hirmiz K; Hussein AA; Agapito J; Pan M
Cureus; 2022 Feb; 14(2):e21878. PubMed ID: 35273848
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Body Radiotherapy - Current Indications.
Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P
Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non-Small-cell Lung Cancer: A Systematic Review.
Falkson CB; Vella ET; Yu E; El-Mallah M; Mackenzie R; Ellis PM; Ung YC
Clin Lung Cancer; 2017 Mar; 18(2):105-121.e5. PubMed ID: 27908621
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic radiotherapy for early lung cancer: Evidence-based approach and future directions.
Chehade S; Palma DA
Rep Pract Oncol Radiother; 2015; 20(6):403-10. PubMed ID: 26696779
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionation and Stereotactic Body Radiation Therapy in Inoperable Locally Advanced Non-small Cell Lung Cancer.
Rico M; Martínez M; Rodríguez M; Rosas L; Barco A; Martínez E
J Clin Transl Res; 2021 Apr; 7(2):199-208. PubMed ID: 34104822
[TBL] [Abstract][Full Text] [Related]
8. GOECP/SEOR clinical guidelines on radiotherapy for malignant pleural mesothelioma.
Luna J; Bobo A; Cabrera-Rodriguez JJ; Pagola M; Martín-Martín M; Ruiz MÁG; Montijano M; Rodríguez A; Pelari-Mici L; Corbacho A; Moreno M; Couñago F
World J Clin Oncol; 2021 Aug; 12(8):581-608. PubMed ID: 34513595
[TBL] [Abstract][Full Text] [Related]
9. Comparison of accelerated hypofractionation and stereotactic body radiotherapy for Stage 1 and node negative Stage 2 non-small cell lung cancer (NSCLC).
Lucas JT; Kuremsky JG; Soike M; Hinson WW; Kearns WT; Hampton CJ; Blackstock AW; Urbanic J
Lung Cancer; 2014 Jul; 85(1):59-65. PubMed ID: 24813936
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy combined with radiotherapy in non-small-cell lung cancer: a review of the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
Couñago F; Rodríguez A; Calvo P; Luna J; Monroy JL; Taboada B; Díaz V; Rodríguez de Dios N
Clin Transl Oncol; 2017 Jan; 19(1):31-43. PubMed ID: 27106020
[TBL] [Abstract][Full Text] [Related]
11. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
12. Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer.
Crockett CB; Samson P; Chuter R; Dubec M; Faivre-Finn C; Green OL; Hackett SL; McDonald F; Robinson C; Shiarli AM; Straza MW; Verhoeff JJC; Werner-Wasik M; Vlacich G; Cobben D
Front Oncol; 2021; 11():617681. PubMed ID: 33777759
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
14. Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥80years old): Extremely safe and effective.
Kreinbrink P; Blumenfeld P; Tolekidis G; Sen N; Sher D; Marwaha G
J Geriatr Oncol; 2017 Sep; 8(5):351-355. PubMed ID: 28739159
[TBL] [Abstract][Full Text] [Related]
15. GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours.
Rico M; Flamarique S; Casares C; García T; López M; Martínez M; Serrano J; Blanco M; Hernanz R; de Ingunza-Barón L; Marcos FJ; Couñago F
World J Clin Oncol; 2021 Apr; 12(4):195-216. PubMed ID: 33959475
[TBL] [Abstract][Full Text] [Related]
16. Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.
Jacobs CD; Gao J; Wang X; Clarke JM; Tong B; Ready NE; Suneja G; Kelsey CR; Torok JA
Clin Lung Cancer; 2020 May; 21(3):238-246. PubMed ID: 31757764
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of stereotactic body radiotherapy in stage III non-small cell lung cancer.
Alcibar OL; Nadal E; Romero Palomar I; Navarro-Martin A
Transl Lung Cancer Res; 2021 Jan; 10(1):529-538. PubMed ID: 33569334
[TBL] [Abstract][Full Text] [Related]
18. Assessing efficacy and safety of stereotactic body radiation therapy for oligometastatic non-small cell lung cancer with epidermal growth factor receptor (EGFR) wild type.
Hu X; Li H; Liu H; Liu Z; Xia T; Zhang J; Wang Y
Transl Cancer Res; 2021 Jan; 10(1):184-194. PubMed ID: 35116250
[TBL] [Abstract][Full Text] [Related]
19. Guideline for radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancer.
Falkson CB; Vella ET; Yu E; El-Mallah M; Mackenzie R; Ellis PM; Ung YC
Curr Oncol; 2017 Feb; 24(1):e44-e49. PubMed ID: 28270731
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated radiation therapy as palliative management for symptomatic and local control of advanced thoracic malignancies.
Ahn GS; Bruggeman AR; Qiao EM; Moiseenko V; Ray X; Sharabi A; Murphy JD; Sandhu AP
Ann Palliat Med; 2021 Oct; 10(10):10360-10368. PubMed ID: 34670382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
